|
⚲
|
| Keyboard |
| Amouyal Philippe
✚
|
|
|---|---|
| CIK # | 0001376854 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001376854] | |
| 4 | [0001376854] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| CAVA Group Inc | |
| Amouyal Philippe | |
| Lexicon Pharmaceuticals Inc | |
| WW International Inc | |
| Blue Buffalo Pet Products Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CAVA Group Inc CAVA
Common Stock
|
2025-06-20 | Grant | 1,767 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2025-06-03 | Grant | 103,806 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2025-06-03 | Grant | 89,312 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2025-05-13 | Option exercise | 36,810 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2025-05-13 | Option exercise | 36,810 | $0.00 | |
|
CAVA Group Inc CAVA
Common Stock
|
2024-06-20 | Grant | 1,307 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2024-05-13 | Grant | 36,810 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2024-05-13 | Grant | 44,906 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2024-04-28 | Option exercise | 8,032 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2024-04-28 | Option exercise | 8,032 | $0.00 | |
|
CAVA Group Inc CAVA
Common Stock
|
2023-11-17 | Buy | 10,000 | $33.18 | 331,800 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2023-11-13 | Buy | 200,000 | $1.01 | 202,000 |
|
CAVA Group Inc CAVA
Common Stock
|
2023-06-20 | Grant | 5,000 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2023-05-21 | Option exercise | 9,302 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2023-05-21 | Option exercise | 9,302 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2023-04-28 | Grant | 8,032 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2023-04-28 | Grant | 12,658 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2022-05-21 | Grant | 9,302 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2022-05-21 | Grant | 14,402 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2022-04-30 | Option exercise | 4,024 | $0.00 | |
| showing 20 of 85 most recent transactions | |||||